If HDA4 were a protein involved in a critical cellular process, such as gene expression regulation or signal transduction, activators of this protein would interact with it to enhance its biological function. The interaction could occur via direct binding to the active site, promoting a conformational change that increases enzymatic activity, or it might involve binding to an allosteric site, thereby affecting the protein's function indirectly. The chemical structures of HDA4 activators would likely be diverse, reflecting the complexity of the protein's structure and the specificity required for effective activation. These activators would need to possess functional groups that facilitate strong and specific interactions with HDA4, and their design would be contingent on an intricate understanding of the protein's biochemistry and biophysics.
In the theoretical pursuit of discovering and understanding HDA4 activators, researchers would likely employ a multi-faceted approach. Initially, computational techniques such as molecular docking and dynamic simulations may be used to predict potential compounds capable of activating HDA4. This in silico screening would save time and resources by identifying promising candidates before any real-world testing. Subsequently, in vitro assays would be indispensable for confirming the activity of these compounds. Techniques such as fluorescence-based assays, calorimetry, or kinetic measurements would help in quantifying the interaction between HDA4 and the activators, as well as the resulting increase in activity. To gain an even deeper understanding, structural studies using methods like X-ray crystallography or cryogenic electron microscopy (cryo-EM) could elucidate the exact binding mode of the activators, revealing how they stabilize the active conformation of HDA4. Such detailed information would be crucial for refining the activator structures to enhance their efficacy and specificity. However, without any empirical evidence or established scientific basis, the concept of HDA4 Activators remains purely theoretical and is not reflective of known chemical entities.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is an HDAC inhibitor that may lead to a feedback mechanism increasing the expression of certain HDACs. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid inhibits HDACs and might induce their expression through compensatory regulatory mechanisms. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a known HDAC inhibitor that could potentially upregulate HDAC expression as a feedback response. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
SAHA, or Vorinostat, is an HDAC inhibitor and may upregulate HDAC expression due to compensatory effects. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 is an HDAC inhibitor that could potentially increase the expression of HDACs as a homeostatic response. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide inhibits sirtuin HDACs and might influence the expression of other HDACs through cross-regulation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol has been shown to modulate sirtuin activity, which could indirectly affect the expression of HDACs. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin exhibits HDAC inhibitory activity and might alter the expression of HDACs as part of its epigenetic effects. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat is a potent HDAC inhibitor and could induce HDAC expression as part of a feedback loop. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin is an HDAC inhibitor that might stimulate the expression of HDACs through compensatory cellular mechanisms. |